• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前弥散加权成像在垂体大腺瘤手术规划中的应用:对神经内镜手术的意义。

The utilization of preoperative DWI for pituitary macroadenoma surgical planning: Implications for neuroendoscopic surgery.

作者信息

Yu Yi, Feng Bao, Ren Yin, Yu Peiming, Zhu Yufu

机构信息

The Affiliated Hospital of Xuzhou Medical University, Department of Neurosurgery, Xuzhou, Jiangsu, China.

出版信息

Endocrine. 2025 Aug 20. doi: 10.1007/s12020-025-04392-8.

DOI:10.1007/s12020-025-04392-8
PMID:40833707
Abstract

PURPOSE

The consistency of pituitary adenomas (PAs) significantly influences the success of complete tumor resection, which is crucial for prognosis in patients. The aim of this study is to use preoperative diffusion-weighted imaging (DWI) to evaluate tumor consistency, thereby assisting surgeons in achieving optimal resection outcomes during neuroendoscopic procedures.

METHODS

We collected clinical data (including age, sex, symptoms, and consistency), pathological data (including collagen content), and imaging data (including tumor size and ADC ratio) from 264 patients with pituitary macroadenomas. Patients were categorized based on intraoperative consistency assessments and postoperative resection rates to analyze the efficacy of DWI in predicting consistency and identifying determinants of the completeness of resection. Correlation analysis and multiple linear regression were used to explore the relationships among the ADC ratio, tumor consistency, and collagen content. Logistic regression was applied to analyze the factors influencing tumor resection.

RESULTS

This study included 264 patients. There were 202 patients with a soft consistency and 62 patients with a hard consistency. A total of 212 patients achieved complete resection. The median ADC ratio for the soft consistency group was 1.27 [1.04, 1.59], and that for the hard consistency group was 0.89 [0.83, 0.94] (P < 0.05). The median collagen content in the soft group was 4.55 [2.13, 6.69], and that in the hard group was 13.91 [10.30, 19.20] (P < 0.05). The ADC ratio was significantly related to the collagen content (ρ = -0.965; 95% CI: -0.973 ~ -0.955; P < 0.05). The ADC ratio was a significant predictor for achieving gross-total tumor resection (OR: 5.714; 95% CI: 1.032-31.628; P < 0.05).

CONCLUSION

For most patients with pituitary macroadenomas, neuroendoscopic transsphenoidal surgery is the first-line treatment. Preoperative apparent diffusion coefficient (ADC) ratios obtained from diffusion-weighted imaging (DWI) can help to evaluate tumor consistency and collagen content, thus guiding neurosurgeons in predicting resection ability under neuroendoscopy and thereby improving preoperative assessments for these patients.

摘要

目的

垂体腺瘤(PAs)的质地一致性对肿瘤全切手术的成功与否有显著影响,这对患者预后至关重要。本研究旨在利用术前扩散加权成像(DWI)评估肿瘤质地,从而协助外科医生在神经内镜手术中实现最佳切除效果。

方法

我们收集了264例垂体大腺瘤患者的临床数据(包括年龄、性别、症状和质地)、病理数据(包括胶原含量)和影像数据(包括肿瘤大小和表观扩散系数[ADC]比值)。根据术中质地评估和术后切除率对患者进行分类,以分析DWI在预测质地和确定切除完整性决定因素方面的有效性。采用相关性分析和多元线性回归探讨ADC比值、肿瘤质地和胶原含量之间的关系。应用逻辑回归分析影响肿瘤切除的因素。

结果

本研究共纳入264例患者。质地柔软的患者有202例,质地坚硬的患者有62例。共有212例患者实现了全切。质地柔软组的ADC比值中位数为1.27[1.04,1.59],质地坚硬组为0.89[0.83,0.94](P<0.05)。柔软组的胶原含量中位数为4.55[2.13,6.69],坚硬组为13.91[10.30,19.20](P<0.05)。ADC比值与胶原含量显著相关(ρ=-0.965;95%CI:-0.973~-0.955;P<0.05)。ADC比值是实现肿瘤全切的重要预测指标(OR:5.714;95%CI:1.032-31.628;P<0.05)。

结论

对于大多数垂体大腺瘤患者,神经内镜经蝶手术是一线治疗方法。术前通过扩散加权成像(DWI)获得的表观扩散系数(ADC)比值有助于评估肿瘤质地和胶原含量,从而指导神经外科医生预测神经内镜下的切除能力,进而改善对这些患者的术前评估。

相似文献

1
The utilization of preoperative DWI for pituitary macroadenoma surgical planning: Implications for neuroendoscopic surgery.术前弥散加权成像在垂体大腺瘤手术规划中的应用:对神经内镜手术的意义。
Endocrine. 2025 Aug 20. doi: 10.1007/s12020-025-04392-8.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.成人生长激素分泌性垂体腺瘤的主要和挽救治疗的手术和非手术干预。
Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2.
4
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
5
Diagnostic Utility of Diffusion-Weighted MRI and Apparent Diffusion Coefficient Values in Differentiating Metastatic From Non-metastatic Lymph Nodes in Cervical Carcinoma.扩散加权磁共振成像及表观扩散系数值在鉴别宫颈癌转移性与非转移性淋巴结中的诊断效用
Cureus. 2025 Jun 4;17(6):e85371. doi: 10.7759/cureus.85371. eCollection 2025 Jun.
6
Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.使用患者特异性截骨导向器的前路全踝关节置换术。
JBJS Essent Surg Tech. 2025 Aug 15;15(3). doi: 10.2106/JBJS.ST.23.00027. eCollection 2025 Jul-Sep.
7
Longitudinal multi-b-value diffusion-weighted imaging in renal transplant recipients: diagnostic efficacy and prognostic value for allograft dysfunction.肾移植受者的纵向多b值扩散加权成像:对移植肾机能障碍的诊断效能及预后价值
Quant Imaging Med Surg. 2025 Aug 1;15(8):7453-7469. doi: 10.21037/qims-2024-2595. Epub 2025 Jul 30.
8
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
9
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多患者,在进行子宫内膜破坏术前使用的术前子宫内膜减薄剂。
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2.
10
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.

本文引用的文献

1
Predicting rectal cancer tumor budding grading based on MRI and CT with multimodal deep transfer learning: A dual-center study.基于多模态深度迁移学习的MRI和CT预测直肠癌肿瘤芽生分级:一项双中心研究。
Heliyon. 2024 Mar 26;10(7):e28769. doi: 10.1016/j.heliyon.2024.e28769. eCollection 2024 Apr 15.
2
Predicting the Consistency of Pituitary Macroadenomas: The Utility of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Measurements for Surgical Planning.预测垂体大腺瘤的质地:扩散加权成像及表观扩散系数测量在手术规划中的应用价值
Diagnostics (Basel). 2024 Feb 25;14(5):493. doi: 10.3390/diagnostics14050493.
3
Characteristics of inflammatory and infectious diseases of the pituitary gland in patients undergoing transsphenoidal surgery.
经蝶窦手术患者垂体炎性和感染性疾病的特征。
Pituitary. 2023 Aug;26(4):451-460. doi: 10.1007/s11102-023-01333-4. Epub 2023 Jun 30.
4
The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas.经蝶窦手术对无功能大腺瘤患者垂体功能的影响。
Endocrine. 2023 Aug;81(2):340-348. doi: 10.1007/s12020-023-03400-z. Epub 2023 May 24.
5
Diffusion-relaxation correlation spectrum imaging for predicting tumor consistency and gross total resection in patients with pituitary adenomas: a preliminary study.弥散-弛豫相关谱成像预测垂体腺瘤患者肿瘤硬度和大体全切除的初步研究。
Eur Radiol. 2023 Oct;33(10):6993-7002. doi: 10.1007/s00330-023-09694-x. Epub 2023 May 6.
6
The learning curve of endoscopic endonasal transsphenoidal surgery for pituitary adenomas with different surgical complexity.不同手术复杂程度的垂体腺瘤经鼻内镜蝶窦手术的学习曲线
Front Surg. 2023 Mar 21;10:1117766. doi: 10.3389/fsurg.2023.1117766. eCollection 2023.
7
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.
8
Complications in Endoscopic Pituitary Surgery.内镜垂体手术的并发症。
Otolaryngol Clin North Am. 2022 Apr;55(2):431-448. doi: 10.1016/j.otc.2021.12.011.
9
Transventricular Preforniceal Approach Combined with Endoscopic Transnasal Surgery for a Giant Pituitary Adenoma: A Case Report and Literature Review.经脑室前穹窿联合鼻内镜手术治疗巨大垂体腺瘤:病例报告及文献复习
NMC Case Rep J. 2021 Dec 22;8(1):827-833. doi: 10.2176/nmccrj.cr.2021-0274. eCollection 2021.
10
Predicting pituitary adenoma consistency with preoperative magnetic resonance elastography.术前磁共振弹性成像预测垂体腺瘤的质地
J Neurosurg. 2021 Oct 29;136(5):1356-1363. doi: 10.3171/2021.6.JNS204425. Print 2022 May 1.